TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
HYFT

ImmunoPrecise Antibodies Ltd.

Healthcare · Biotechnology

1.30$ -2.9% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for ImmunoPrecise Antibodies Ltd. (HYFT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 09/14/2026.

Next report 09/14/2026
Last report 09/14/2026
Earnings surprise by quarter (%)
Q4 23 · 30.0 % 23 Q1 24 · -14.3 % 24 Q2 24 · -25.0 % 24 Q4 24 · 14.3 % 24 Q1 25 · -666.7 % 25 Q2 25 · 0.0 % 25 Q3 25 · -109.3 % 25 Q4 25 · -400.0 % 25 Q1 26 · -50.0 % 26 Q2 26 · -20.0 % 26 Q3 26 · -80.0 % 26

EPS estimate beaten

Full history 3 of 14 quarters (21%)

Earnings Call Transcripts

Search all transcripts →

  • 09/14/2026 Earnings Call Q2 2026 Open →
  • 07/22/2026 Earnings Call Q1 2026 Open →
  • 03/12/2026 Earnings Call Q4 2025 Open →
  • 12/15/2025 Earnings Call Q3 2025 Open →
  • 09/15/2025 Earnings Call Q2 2025 Open →
  • 07/29/2025 Earnings Call Q1 2025 Open →
  • 03/28/2025 Earnings Call Q4 2024 Open →
  • 12/10/2024 Earnings Call Q3 2024 Open →
  • 09/16/2024 Earnings Call Q2 2024 Open →
  • 07/29/2024 Earnings Call Q1 2024 Open →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?